AXSM
$179.18-1.59%
as of close, Oct 2, 2026
☾ AH $179.18 -1.59%
Axsome Therapeutics Inc.Stock · Health CareNasdaq Composite 0.03%Russell 1000 0.02%US Stock Market 0.01%Russell 3000 0.01%
AXSM SEC filings (2026)
CIK 1579428 · Pharmaceutical Preparations (SIC 2834) · incorporated in DE · fiscal year ends in December
669 filings on EDGAR since 2013 · 12 annual, 34 quarterly, 233 current · financial statements · earnings
Latest 10-K
Feb 23, 2026
fiscal year to Dec 31, 2025
Latest 10-Q
Aug 10, 2026
quarter to Jun 30, 2026
Latest 8-K
Aug 10, 2026
Results of operations; Other events
Last earnings release
Aug 10, 2026
−$0.99 vs −$0.99 · ▲ 3.8%
Filings on file
669
since 2013, 281 insider forms
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by what they covered, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
September 2026
August 2026
- Aug 10EarningsEarnings release — EPS −$0.99 vs −$0.99 est. (+0.0%); revenue $218.4M (+46% y/y) 3.8%
- Aug 10ReportQuarterly report, Q2 2026 — revenue $218.4M (+46% y/y), net income −$51.3M, EPS −$0.99
- Aug 6Insider saleTABUTEAU HERRIOT (Chief Executive Officer · Director · 10% owner) sold 4,660 shares for $997K at $213.95 under a 10b5-1 plan
- Aug 5Insider saleTABUTEAU HERRIOT (Chief Executive Officer · Director · 10% owner) sold 45,004 shares for $9.5M at $212.01 under a 10b5-1 plan
July 2026
June 2026
- Jun 11Insider saleJEFFS ROGER (Director) sold 286 shares for $71K at $249.12 under a 10b5-1 plan
- Jun 10Insider saleColeman Mark (Director) sold 643 shares for $160K at $249.00 under a 10b5-1 plan
- Jun 10Insider saleMahony Susan (Director) sold 300 shares for $74K at $246.18 under a 10b5-1 plan
- Jun 10Insider saleJEFFS ROGER (Director) sold 286 shares for $70K at $246.18 under a 10b5-1 plan
- Jun 9Insider saleTABUTEAU HERRIOT (Chief Executive Officer · Director · 10% owner) sold 49,670 shares for $12.0M at $241.01 under a 10b5-1 plan
- Jun 9Insider salePizzie Nick (Chief Financial Officer) sold 33,000 shares for $7.9M at $240.09 under a 10b5-1 plan
- Jun 9Insider saleMahony Susan (Director) sold 300 shares for $71K at $237.21 under a 10b5-1 plan
- Jun 98-K8-K · Directors or officers; compensation
- Jun 98-K8-K · Shareholder vote results
- Jun 38-K8-K · Other events
- Jun 2Insider saleColeman Mark (Director) sold 5,537 shares for $1.2M at $223.39 under a 10b5-1 plan
- Jun 1Insider saleColeman Mark (Director) sold 6,000 shares for $1.4M at $230.30 under a 10b5-1 plan
May 2026
- May 29Insider saleColeman Mark (Director) sold 6,000 shares for $1.4M at $233.46 under a 10b5-1 plan
- May 5Insider saleJacobson Mark L. (Chief Operating Officer) sold 233 shares for $53K at $228.18 under a 10b5-1 plan
- May 4EarningsEarnings release — EPS −$1.26 vs −$0.85 est. (−48.2%); revenue $191.2M (+57% y/y) 8.3%
- May 4ReportQuarterly report, Q1 2026 — revenue $191.2M (+57% y/y), net income −$64.5M, EPS −$1.26
- May 4Insider saleJacobson Mark L. (Chief Operating Officer) sold 4,517 shares for $1.0M at $227.94 under a 10b5-1 plan
April 2026
- Apr 308-K8-K · Other events
- Apr 24ProxyProxy · Annual report to shareholders
- Apr 24ProxyProxy · Additional proxy materials
- Apr 24ProxyProxy · Proxy statement
- Apr 22Insider saleMaizel Ari (Chief Commercial Officer) sold 7,500 shares for $1.4M at $182.42 under a 10b5-1 plan
- Apr 18-K8-K · Other events
February 2026
- Feb 26Insider saleJacobson Mark L. (Chief Operating Officer) sold 35,378 shares for $5.7M at $161.88 under a 10b5-1 plan
- Feb 26Insider saleColeman Mark (Director) sold 25,000 shares for $4.0M at $161.11 under a 10b5-1 plan
- Feb 23EarningsEarnings release — EPS −$0.71 vs −$0.70 est. (−1.4%); revenue $196.0M (+65% y/y) 4.9%
- Feb 23ReportAnnual report, FY2025 — revenue $638.5M (+66% y/y), net income −$183.2M, EPS −$3.68
- Feb 178-K8-K · Other events
- Feb 2Insider saleTABUTEAU HERRIOT (Chief Executive Officer · Director · 10% owner) sold 32,410 shares for $6.0M at $185.60 under a 10b5-1 plan
January 2026
- Jan 22Insider salePizzie Nick (Chief Financial Officer) sold 12,000 shares for $2.3M at $187.92 under a 10b5-1 plan
- Jan 21Insider saleMaizel Ari (Chief Commercial Officer) sold 7,500 shares for $1.4M at $184.44 under a 10b5-1 plan
- Jan 128-K8-K · Results of operations; Other events
- Jan 7Insider saleTABUTEAU HERRIOT (Chief Executive Officer · Director · 10% owner) sold 31,261 shares for $5.3M at $170.38 under a 10b5-1 plan
- Jan 6Insider saleTABUTEAU HERRIOT (Chief Executive Officer · Director · 10% owner) sold 29,450 shares for $5.1M at $172.33 under a 10b5-1 plan
- Jan 5Insider saleTABUTEAU HERRIOT (Chief Executive Officer · Director · 10% owner) sold 78,703 shares for $13.5M at $171.28 under a 10b5-1 plan
December 2025
- Dec 31Insider saleSaad Mark E (Director) sold 37,577 shares for $6.2M at $165.18 under a 10b5-1 plan
- Dec 318-K8-K · Other events
November 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $100.9M in 26 sales and bought nothing on the open market; 62 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Sep 3, 2026Form 4 | Jacobson Mark L.Chief Operating OfficerSold · $2.1M · 10,000 sh · 10b5-1 |
| Aug 6, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerSold · $997K · 4,660 sh · 10b5-1 |
| Aug 5, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerSold · $9.5M · 45,004 sh · 10b5-1 |
| Jul 1, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerSold · $11.9M · 49,666 sh · 10b5-1 |
| Jun 11, 2026Form 4 | JEFFS ROGERDirectorSold · $71K · 286 sh · 10b5-1 |
| Jun 10, 2026Form 4 | Coleman MarkDirectorSold · $160K · 643 sh · 10b5-1 |
| Jun 10, 2026Form 4 | Mahony SusanDirectorSold · $74K · 300 sh · 10b5-1 |
| Jun 10, 2026Form 4 | JEFFS ROGERDirectorSold · $70K · 286 sh · 10b5-1 |
| Jun 9, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerSold · $12.0M · 49,670 sh · 10b5-1 |
| Jun 9, 2026Form 4 | Pizzie NickChief Financial OfficerSold · $7.9M · 33,000 sh · 10b5-1 |
| Jun 9, 2026Form 4 | Mahony SusanDirectorSold · $71K · 300 sh · 10b5-1 |
| Jun 2, 2026Form 4 | Coleman MarkDirectorSold · $1.2M · 5,537 sh · 10b5-1 |
| Jun 1, 2026Form 4 | Coleman MarkDirectorSold · $1.4M · 6,000 sh · 10b5-1 |
| May 29, 2026Form 4 | Coleman MarkDirectorSold · $1.4M · 6,000 sh · 10b5-1 |
| May 5, 2026Form 4 | Jacobson Mark L.Chief Operating OfficerSold · $53K · 233 sh · 10b5-1 |
| May 4, 2026Form 4 | Jacobson Mark L.Chief Operating OfficerSold · $1.0M · 4,517 sh · 10b5-1 |
| Apr 22, 2026Form 4 | Maizel AriChief Commercial OfficerSold · $1.4M · 7,500 sh · 10b5-1 |
| Feb 26, 2026Form 4 | Jacobson Mark L.Chief Operating OfficerSold · $5.7M · 35,378 sh · 10b5-1 |
| Feb 26, 2026Form 4 | Coleman MarkDirectorSold · $4.0M · 25,000 sh · 10b5-1 |
| Feb 2, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerSold · $6.0M · 32,410 sh · 10b5-1 |
| Jan 22, 2026Form 4 | Pizzie NickChief Financial OfficerSold · $2.3M · 12,000 sh · 10b5-1 |
| Jan 21, 2026Form 4 | Maizel AriChief Commercial OfficerSold · $1.4M · 7,500 sh · 10b5-1 |
| Jan 7, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerSold · $5.3M · 31,261 sh · 10b5-1 |
| Jan 6, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerSold · $5.1M · 29,450 sh · 10b5-1 |
| Jan 5, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerSold · $13.5M · 78,703 sh · 10b5-1 |
| Dec 31, 2025Form 4 | Saad Mark EDirectorSold · $6.2M · 37,577 sh · 10b5-1 |
Awards, exercises, withholding and plan purchases · 62 transactions
| Date | Insider |
|---|---|
| Sep 3, 2026Form 4 | Jacobson Mark L.Chief Operating OfficerExercise or conversion · $130K · 10,000 sh · 10b5-1 |
| Sep 3, 2026Form 4 | Jacobson Mark L.Chief Operating OfficerExercise or conversion · Stock Option (Right to Buy) · $0 · 10,000 sh · 10b5-1 |
| Aug 6, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · $23K · 4,660 sh · 10b5-1 |
| Aug 6, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · Stock Option (Right to Buy) · $0 · 4,660 sh · 10b5-1 |
| Aug 5, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · $223K · 45,004 sh · 10b5-1 |
| Aug 5, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · Stock Option (Right to Buy) · $0 · 45,004 sh · 10b5-1 |
| Jul 1, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · $246K · 49,666 sh · 10b5-1 |
| Jul 1, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · Stock Option (Right to Buy) · $0 · 49,666 sh · 10b5-1 |
| Jun 9, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · $246K · 49,670 sh · 10b5-1 |
| Jun 9, 2026Form 4 | Pizzie NickChief Financial OfficerExercise or conversion · $116K · 33,000 sh · 10b5-1 |
| Jun 9, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · Stock Option (Right to Buy) · $0 · 49,670 sh · 10b5-1 |
| Jun 9, 2026Form 4 | Pizzie NickChief Financial OfficerExercise or conversion · Stock Option (Right to Buy) · $0 · 33,000 sh · 10b5-1 |
| Jun 8, 2026Form 4 | Coleman MarkDirectorExercise or conversion · — · 1,429 sh · 10b5-1 |
| Jun 8, 2026Form 4 | Coleman MarkDirectorExercise or conversion · Restricted Stock Units · $0 · 1,429 sh · 10b5-1 |
| Jun 8, 2026Form 4 | Mahony SusanDirectorExercise or conversion · — · 1,429 sh · 10b5-1 |
| Jun 8, 2026Form 4 | Mahony SusanDirectorExercise or conversion · Restricted Stock Units · $0 · 1,429 sh · 10b5-1 |
| Jun 8, 2026Form 4 | Saad Mark EDirectorExercise or conversion · — · 1,429 sh |
| Jun 8, 2026Form 4 | Saad Mark EDirectorExercise or conversion · Restricted Stock Units · $0 · 1,429 sh |
| Jun 8, 2026Form 4 | JEFFS ROGERDirectorExercise or conversion · — · 1,429 sh |
| Jun 8, 2026Form 4 | JEFFS ROGERDirectorExercise or conversion · Restricted Stock Units · $0 · 1,429 sh |
| Jun 5, 2026Form 4 | JEFFS ROGERDirectorAward · Restricted Stock Units · $0 · 1,721 sh |
| Jun 5, 2026Form 4 | Saad Mark EDirectorAward · Restricted Stock Units · $0 · 1,721 sh |
| Jun 5, 2026Form 4 | Mahony SusanDirectorAward · Restricted Stock Units · $0 · 1,721 sh |
| Jun 5, 2026Form 4 | Coleman MarkDirectorAward · Restricted Stock Units · $0 · 1,721 sh |
| May 5, 2026Form 4 | Jacobson Mark L.Chief Operating OfficerExercise or conversion · $3,017 · 233 sh · 10b5-1 |
| May 5, 2026Form 4 | Jacobson Mark L.Chief Operating OfficerExercise or conversion · Stock Option (Right to Buy) · $0 · 233 sh · 10b5-1 |
| May 4, 2026Form 4 | Jacobson Mark L.Chief Operating OfficerExercise or conversion · $58K · 4,517 sh · 10b5-1 |
| May 4, 2026Form 4 | Jacobson Mark L.Chief Operating OfficerExercise or conversion · Stock Option (Right to Buy) · $0 · 4,517 sh · 10b5-1 |
| Apr 22, 2026Form 4 | Maizel AriChief Commercial OfficerExercise or conversion · $530K · 7,500 sh · 10b5-1 |
| Apr 22, 2026Form 4 | Maizel AriChief Commercial OfficerExercise or conversion · Stock Option (Right to Buy) · $0 · 7,500 sh · 10b5-1 |
| Apr 21, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerAward · Performance Stock Units · $0 · 24,081 sh |
| Apr 21, 2026Form 4 | Jacobson Mark L.Chief Operating OfficerAward · Performance Stock Units · $0 · 8,669 sh |
| Apr 21, 2026Form 4 | Pizzie NickChief Financial OfficerAward · Performance Stock Units · $0 · 8,188 sh |
| Apr 21, 2026Form 4 | Murdock Hunter R.General CounselAward · Performance Stock Units · $0 · 7,224 sh |
| Apr 21, 2026Form 4 | Maizel AriChief Commercial OfficerAward · Performance Stock Units · $0 · 7,224 sh |
| Feb 26, 2026Form 4 | Jacobson Mark L.Chief Operating OfficerExercise or conversion · $101K · 35,378 sh · 10b5-1 |
| Feb 26, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerAward · Restricted Stock Units · $0 · 54,623 sh |
| Feb 26, 2026Form 4 | Jacobson Mark L.Chief Operating OfficerExercise or conversion · Stock Option (Right to Buy) · $0 · 35,378 sh · 10b5-1 |
| Feb 26, 2026Form 4 | Jacobson Mark L.Chief Operating OfficerAward · Restricted Stock Units · $0 · 19,663 sh |
| Feb 26, 2026Form 4 | Pizzie NickChief Financial OfficerAward · Restricted Stock Units · $0 · 18,570 sh |
| Feb 26, 2026Form 4 | Maizel AriChief Commercial OfficerAward · Restricted Stock Units · $0 · 16,385 sh |
| Feb 26, 2026Form 4 | Murdock Hunter R.General CounselAward · Restricted Stock Units · $0 · 16,385 sh |
| Feb 23, 2026Form 4 | Coleman MarkDirectorExercise or conversion · $31K · 6,250 sh |
| Feb 23, 2026Form 4 | Coleman MarkDirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 6,250 sh |
| Feb 20, 2026Form 4 | Coleman MarkDirectorExercise or conversion · $62K · 12,485 sh |
| Feb 20, 2026Form 4 | Coleman MarkDirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 12,485 sh |
| Feb 10, 2026Form 4 | Coleman MarkDirectorExercise or conversion · $42K · 5,193 sh |
| Feb 10, 2026Form 4 | Coleman MarkDirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 5,193 sh |
| Feb 2, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · $260K · 32,410 sh · 10b5-1 |
| Feb 2, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · Stock Option (Right to Buy) · $0 · 32,410 sh · 10b5-1 |
| Jan 22, 2026Form 4 | Pizzie NickChief Financial OfficerExercise or conversion · $42K · 12,000 sh · 10b5-1 |
| Jan 22, 2026Form 4 | Pizzie NickChief Financial OfficerExercise or conversion · Stock Option (Right to Buy) · $0 · 12,000 sh · 10b5-1 |
| Jan 21, 2026Form 4 | Maizel AriChief Commercial OfficerExercise or conversion · $530K · 7,500 sh · 10b5-1 |
| Jan 21, 2026Form 4 | Maizel AriChief Commercial OfficerExercise or conversion · Stock Option (Right to Buy) · $0 · 7,500 sh · 10b5-1 |
| Jan 7, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · $251K · 31,261 sh · 10b5-1 |
| Jan 7, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · Stock Option (Right to Buy) · $0 · 31,261 sh · 10b5-1 |
| Jan 6, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · $236K · 29,450 sh · 10b5-1 |
| Jan 6, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · Stock Option (Right to Buy) · $0 · 29,450 sh · 10b5-1 |
| Jan 5, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · $631K · 78,703 sh · 10b5-1 |
| Jan 5, 2026Form 4 | TABUTEAU HERRIOTChief Executive Officer · Director · 10% ownerExercise or conversion · Stock Option (Right to Buy) · $0 · 78,703 sh · 10b5-1 |
| Dec 31, 2025Form 4 | Saad Mark EDirectorExercise or conversion · $205K · 37,577 sh · 10b5-1 |
| Dec 31, 2025Form 4 | Saad Mark EDirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 37,577 sh · 10b5-1 |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K is described by its items. A form opens the document on EDGAR, or the filing’s index where it furnishes exhibits (an earnings release is the 8-K’s Exhibit 99.1).
2026 · 17 filings
| Filed | What it is |
|---|---|
| Aug 10, 202610-Q | Quarterly report, Q2 2026 — revenue $218.4M (+46% y/y), net income −$51.3M, EPS −$0.99 |
| Aug 10, 20268-K | Earnings release — EPS −$0.99 vs −$0.99 est. (+0.0%); revenue $218.4M (+46% y/y) 3.8% |
| Jul 15, 20268-K | Other events |
| Jun 9, 20268-K | Directors or officers; compensation |
| Jun 9, 20268-K | Shareholder vote results |
| Jun 3, 20268-K | Other events |
| May 4, 202610-Q | Quarterly report, Q1 2026 — revenue $191.2M (+57% y/y), net income −$64.5M, EPS −$1.26 |
| May 4, 20268-K | Earnings release — EPS −$1.26 vs −$0.85 est. (−48.2%); revenue $191.2M (+57% y/y) 8.3% |
| Apr 30, 20268-K | Other events |
| Apr 24, 2026ARS | Annual report to shareholders |
| Apr 24, 2026DEFA14A | Additional proxy materials |
| Apr 24, 2026DEF 14A | Proxy statement |
| Apr 1, 20268-K | Other events |
| Feb 23, 202610-K | Annual report, FY2025 — revenue $638.5M (+66% y/y), net income −$183.2M, EPS −$3.68 |
| Feb 23, 20268-K | Earnings release — EPS −$0.71 vs −$0.70 est. (−1.4%); revenue $196.0M (+65% y/y) 4.9% |
| Feb 17, 20268-K | Other events |
| Jan 12, 20268-K | Results of operations; Other events |
2025 · 25 filings
| Filed | What it is |
|---|---|
| Dec 31, 20258-K | Other events |
| Nov 3, 202510-Q | Quarterly report, Q3 2025 — revenue $171.0M (+63% y/y), net income −$47.2M, EPS −$0.94 |
| Nov 3, 20258-K | Earnings release — EPS −$0.94 vs −$0.82 est. (−14.6%); revenue $171.0M (+63% y/y) 0.6% |
| Aug 20, 20258-K | Other events |
| Aug 4, 202510-Q | Quarterly report, Q2 2025 — revenue $150.0M (+72% y/y), net income −$48.0M, EPS −$0.97 |
| Aug 4, 20258-K | Results of operations; Other events |
| Jun 10, 20258-K | Other events |
| Jun 9, 20258-K | Shareholder vote results |
| Jun 9, 20258-K | Other events |
| May 27, 20258-K | Other events |
| May 13, 20258-K | Material definitive agreement; Termination of a material agreement; New financial obligation; Unregistered sale of equity; Other events |
| May 5, 202510-Q | Quarterly report, Q1 2025 — revenue $121.5M (+62% y/y), net income −$59.4M, EPS −$1.22 |
| May 5, 20258-K | Results of operations; Other events |
| Apr 25, 2025ARS | Annual report to shareholders |
| Apr 25, 2025DEFA14A | Additional proxy materials |
| Apr 25, 2025DEF 14A | Proxy statement |
| Apr 1, 20258-K | Other events |
| Mar 25, 20258-K | Other events |
| Mar 5, 20258-K | Other events |
| Mar 3, 20258-K | Other events |
| Feb 18, 202510-K | Annual report, FY2024 — revenue $385.7M (+43% y/y), net income −$287.2M, EPS −$5.99 |
| Feb 18, 20258-K | Results of operations; Other events |
| Feb 10, 20258-K | Other events |
| Jan 31, 20258-K | Other events |
| Jan 13, 20258-K | Results of operations; Other events |
2024 · 24 filings
| Filed | What it is |
|---|---|
| Dec 30, 20248-K | Other events |
| Nov 26, 20248-K | Other events |
| Nov 12, 202410-Q | Quarterly report, Q3 2024 — revenue $104.8M (+81% y/y), net income −$64.6M, EPS −$1.34 |
| Nov 12, 20248-K | Results of operations; Other events |
| Oct 1, 20248-K | Material definitive agreement |
| Sep 4, 20248-K | Other events |
| Aug 21, 20248-K | Other events |
| Aug 5, 202410-Q | Quarterly report, Q2 2024 — revenue $87.2M (+87% y/y), net income −$79.3M, EPS −$1.67 |
| Aug 5, 20248-K | Results of operations |
| Jun 11, 20248-K | Shareholder vote results |
| Jun 5, 20248-K | Other events |
| May 6, 202410-Q | Quarterly report, Q1 2024 — revenue $75.0M (−21% y/y), net income −$68.4M, EPS −$1.44 |
| May 6, 20248-K | Results of operations |
| Apr 26, 2024ARS | Annual report to shareholders |
| Apr 26, 2024DEF 14A | Proxy statement |
| Apr 1, 20248-K | Other events |
| Mar 25, 20248-K | Other events |
| Mar 25, 20248-K | Other events |
| Mar 19, 20248-K | Other events |
| Feb 23, 202410-K | Annual report, FY2023 — revenue $270.6M (+441% y/y), net income −$239.2M, EPS −$5.27 |
| Feb 20, 20248-K | Other events |
| Feb 20, 20248-K | Results of operations |
| Jan 8, 20248-K | Other events |
| Jan 4, 20248-K | Results of operations; Other events |
2023 · 25 filings — 19 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 6, 202310-Q | Quarterly report, Q3 2023 — revenue $57.8M (+243% y/y), net income −$62.2M, EPS −$1.32 |
| Aug 7, 202310-Q | Quarterly report, Q2 2023 — revenue $46.7M (+429% y/y), net income −$67.2M, EPS −$1.54 |
| May 9, 202310-Q | Quarterly report, Q1 2023 — revenue $94.6M, net income −$11.2M, EPS −$0.26 |
| Apr 21, 2023ARS | Annual report to shareholders |
| Apr 21, 2023DEF 14A | Proxy statement |
| Feb 28, 202310-K | Annual report, FY2022 — revenue $50.0M, net income −$187.1M, EPS −$4.60 |
19 current reports (8-K) not listed; the year is on EDGAR.
2022 · 35 filings — 28 × 8-K, 3 × 10-Q, 2 × 8-K/A and 2 other forms
| Filed | What it is |
|---|---|
| Nov 7, 202210-Q | Quarterly report, Q3 2022 — revenue $16.8M, net income −$44.8M, EPS −$1.07 |
| Aug 9, 202210-Q | Quarterly report, Q2 2022 — revenue $8.8M, net income −$41.4M, EPS −$1.06 |
| May 2, 202210-Q | Quarterly report, Q1 2022 — net income −$39.6M, EPS −$1.06 |
| Apr 22, 2022DEF 14A | Proxy statement |
| Mar 1, 202210-K | Annual report, FY2021 — net income −$130.4M, EPS −$3.47 |
30 current reports (8-K) not listed; the year is on EDGAR.
2021 · 20 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
| Filed | What it is |
|---|---|
| Nov 8, 202110-Q | Quarterly report, Q3 2021 — revenue $0, net income −$34.9M, EPS −$0.93 |
| Aug 9, 202110-Q | Quarterly report, Q2 2021 — net income −$32.3M, EPS −$0.86 |
| May 10, 202110-Q | Quarterly report, Q1 2021 — net income −$29.3M |
| Apr 23, 2021DEF 14A | Proxy statement |
| Mar 1, 202110-K | Annual report, FY2020 — net income −$102.9M, EPS −$2.77 |
15 current reports (8-K) not listed; the year is on EDGAR.
2020 · 39 filings — 30 × 8-K, 3 × 10-Q, 2 × DEFA14A and 4 other forms
| Filed | What it is |
|---|---|
| Nov 6, 202010-Q/A | Quarterly report, amended |
| Nov 5, 202010-Q | Quarterly report, Q3 2020 — net income −$22.9M |
| Aug 10, 202010-Q | Quarterly report, Q2 2020 — net income −$18.3M |
| May 26, 2020DEFA14A | Additional proxy materials |
| May 11, 202010-Q | Quarterly report, Q1 2020 — net income −$32.5M |
| Apr 21, 2020DEFA14A | Additional proxy materials |
| Apr 21, 2020DEF 14A | Proxy statement |
| Mar 12, 202010-K | Annual report, FY2019 — net income −$68.3M |
31 current reports (8-K) not listed; the year is on EDGAR.
2019 · 38 filings — 33 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
| Filed | What it is |
|---|---|
| Nov 7, 201910-Q | Quarterly report, Q3 2019 — net income −$19.1M |
| Aug 8, 201910-Q | Quarterly report, Q2 2019 — net income −$13.8M |
| May 9, 201910-Q | Quarterly report, Q1 2019 — net income −$10.6M |
| Apr 26, 2019DEF 14A | Proxy statement |
| Mar 15, 201910-K | Annual report, FY2018 — net income −$31.0M |
33 current reports (8-K) not listed; the year is on EDGAR.
2018 · 27 filings — 22 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
| Filed | What it is |
|---|---|
| Nov 9, 201810-Q | Quarterly report, Q3 2018 — net income −$8.3M |
| Aug 8, 201810-Q | Quarterly report, Q2 2018 — net income −$8.3M |
| May 8, 201810-Q | Quarterly report, Q1 2018 — net income −$4.8M |
| Apr 30, 2018DEF 14A | Proxy statement |
| Mar 7, 201810-K | Annual report, FY2017 — net income −$28.9M |
22 current reports (8-K) not listed; the year is on EDGAR.
2017 · 28 filings — 23 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
| Filed | What it is |
|---|---|
| Nov 8, 201710-Q | Quarterly report, Q3 2017 — net income −$6.4M |
| Aug 9, 201710-Q | Quarterly report, Q2 2017 — net income −$7.1M |
| May 9, 201710-Q | Quarterly report, Q1 2017 — net income −$8.0M |
| Apr 28, 2017DEF 14A | Proxy statement |
| Mar 7, 201710-K | Annual report, FY2016 — net income −$27.2M |
23 current reports (8-K) not listed; the year is on EDGAR.
2016 · 19 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2015 · 1 filing — 1 × 8-K
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 64 filings — 37 × 4, 25 × 144, 1 × 144/A and 1 other form
| Filed | What it is |
|---|---|
| Sep 3, 20264 | Insider transaction (Form 4) |
| Sep 3, 2026144 | Notice of proposed sale (Form 144) |
| Aug 7, 20264 | Insider transaction (Form 4) |
| Aug 6, 2026144 | Notice of proposed sale (Form 144) |
| Aug 5, 2026144 | Notice of proposed sale (Form 144) |
| Jul 1, 20264 | Insider transaction (Form 4) |
| Jul 1, 2026144 | Notice of proposed sale (Form 144) |
| Jun 11, 20264 | Insider transaction (Form 4) |
| Jun 11, 2026144 | Notice of proposed sale (Form 144) |
| Jun 10, 20264 | Insider transaction (Form 4) |
| Jun 10, 20264 | Insider transaction (Form 4) |
| Jun 10, 20264 | Insider transaction (Form 4) |
| Jun 10, 20264 | Insider transaction (Form 4) |
| Jun 10, 2026144 | Notice of proposed sale (Form 144) |
| Jun 10, 2026144 | Notice of proposed sale (Form 144) |
| Jun 10, 2026144 | Notice of proposed sale (Form 144) |
| Jun 9, 2026144 | Notice of proposed sale (Form 144) |
| Jun 9, 20264 | Insider transaction (Form 4) |
| Jun 9, 20264 | Insider transaction (Form 4) |
| Jun 9, 20264 | Insider transaction (Form 4) |
| Jun 9, 20264 | Insider transaction (Form 4) |
| Jun 9, 20264 | Insider transaction (Form 4) |
| Jun 9, 20264 | Insider transaction (Form 4) |
| Jun 9, 2026144 | Notice of proposed sale (Form 144) |
| Jun 9, 2026144 | Notice of proposed sale (Form 144) |
The newest 25 of 64 shown; the full year is on EDGAR.
2025 · 71 filings — 35 × 144, 31 × 4, 3 × SCHEDULE 13G/A and 2 other forms
| Filed | What it is |
|---|---|
| Dec 31, 2025144 | Notice of proposed sale (Form 144) |
| Dec 4, 20254 | Insider transaction (Form 4) |
| Dec 4, 2025144 | Notice of proposed sale (Form 144) |
| Dec 3, 2025144 | Notice of proposed sale (Form 144) |
| Dec 2, 2025144 | Notice of proposed sale (Form 144) |
| Nov 5, 2025144 | Notice of proposed sale (Form 144) |
| Nov 5, 20254 | Insider transaction (Form 4) |
| Nov 4, 2025144 | Notice of proposed sale (Form 144) |
| Nov 3, 2025144 | Notice of proposed sale (Form 144) |
| Nov 3, 2025S-3ASR | Automatic shelf registration |
| Oct 8, 20254 | Insider transaction (Form 4) |
| Oct 8, 2025144 | Notice of proposed sale (Form 144) |
| Oct 7, 2025144 | Notice of proposed sale (Form 144) |
| Oct 6, 2025144 | Notice of proposed sale (Form 144) |
| Sep 22, 20254 | Insider transaction (Form 4) |
| Sep 22, 2025144 | Notice of proposed sale (Form 144) |
| Sep 17, 20254 | Insider transaction (Form 4) |
| Sep 16, 20254 | Insider transaction (Form 4) |
| Sep 16, 2025144 | Notice of proposed sale (Form 144) |
| Sep 16, 2025144 | Notice of proposed sale (Form 144) |
| Sep 15, 2025144 | Notice of proposed sale (Form 144) |
| Sep 12, 2025144 | Notice of proposed sale (Form 144) |
| Sep 9, 20254 | Insider transaction (Form 4) |
| Sep 5, 20254 | Insider transaction (Form 4) |
| Sep 5, 2025144 | Notice of proposed sale (Form 144) |
The newest 25 of 71 shown; the full year is on EDGAR.
2024 · 32 filings — 18 × 4, 8 × 144, 4 × SC 13G/A and 2 other forms
| Filed | What it is |
|---|---|
| Nov 20, 20244 | Insider transaction (Form 4) |
| Oct 24, 20243 | Initial insider holdings (Form 3) |
| Sep 11, 20244 | Insider transaction (Form 4) |
| Sep 11, 2024144 | Notice of proposed sale (Form 144) |
| Aug 9, 20244 | Insider transaction (Form 4) |
| Aug 9, 2024144 | Notice of proposed sale (Form 144) |
| Aug 5, 2024S-8 | Employee stock plan registration |
| Jun 11, 20244 | Insider transaction (Form 4) |
| Jun 11, 20244 | Insider transaction (Form 4) |
| Jun 11, 20244 | Insider transaction (Form 4) |
| Jun 11, 20244 | Insider transaction (Form 4) |
| May 29, 20244 | Insider transaction (Form 4) |
| May 29, 20244 | Insider transaction (Form 4) |
| May 29, 2024144 | Notice of proposed sale (Form 144) |
| May 29, 2024144 | Notice of proposed sale (Form 144) |
| May 28, 2024144 | Notice of proposed sale (Form 144) |
| Apr 1, 20244 | Insider transaction (Form 4) |
| Apr 1, 2024144 | Notice of proposed sale (Form 144) |
| Mar 15, 20244 | Insider transaction (Form 4) |
| Mar 15, 2024144 | Notice of proposed sale (Form 144) |
| Mar 14, 2024144 | Notice of proposed sale (Form 144) |
| Feb 29, 20244 | Insider transaction (Form 4) |
| Feb 29, 20244 | Insider transaction (Form 4) |
| Feb 29, 20244 | Insider transaction (Form 4) |
| Feb 29, 20244 | Insider transaction (Form 4) |
The newest 25 of 32 shown; the full year is on EDGAR.
2023 · 26 filings — 13 × 4, 5 × SC 13G/A, 2 × 424B5 and 4 other forms
Counted, not listed; the year is on EDGAR.
2022 · 20 filings — 10 × 4, 3 × SC 13G/A, 2 × 424B5 and 4 other forms
Counted, not listed; the year is on EDGAR.
2021 · 22 filings — 16 × 4, 2 × SC 13G, 2 × SEC STAFF LETTER and 2 other forms
Counted, not listed; the year is on EDGAR.
2020 · 20 filings — 14 × 4, 2 × 4/A, 1 × 3 and 3 other forms
Counted, not listed; the year is on EDGAR.
2019 · 28 filings — 21 × 4, 3 × 424B5, 1 × 3 and 3 other forms
Counted, not listed; the year is on EDGAR.
2018 · 18 filings — 10 × 4, 5 × SC 13G/A, 1 × 3 and 2 other forms
Counted, not listed; the year is on EDGAR.
2017 · 20 filings — 8 × 4, 4 × 424B5, 3 × SC 13G/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2016 · 10 filings — 5 × 4, 1 × CORRESP, 1 × EFFECT and 3 other forms
Counted, not listed; the year is on EDGAR.
2015 · 36 filings — 11 × 4, 7 × 3, 4 × CORRESP and 13 other forms
Counted, not listed; the year is on EDGAR.
2014 · 1 filing — 1 × D
Counted, not listed; the year is on EDGAR.
2013 · 3 filings — 2 × D, 1 × D/A
Counted, not listed; the year is on EDGAR.
About this data
Axsome Therapeutics Inc. (AXSM) has 669 filings on EDGAR going back to 2013: 12 annual reports, 34 quarterly reports and 233 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 23, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Aug 10, 2026, covered results of operations; other events. Over the last 13 months insiders sold $100.9M in 26 sales and bought nothing on the open market; 62 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been Axsome Therapeutics Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read AXSM's latest 10-K?
- AXSM's latest annual report, a 10-K, was filed on Feb 23, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did AXSM last file an 8-K?
- On Aug 10, 2026: results of operations; other events. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 10, 2026.
- Are AXSM insiders buying or selling?
- Over the last 13 months insiders sold $100.9M in 26 sales and bought nothing on the open market; 62 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Jacobson Mark L. (Chief Operating Officer) sold 10,000 shares on Sep 3, 2026 for $2.1M, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has AXSM made?
- 669 filings are on EDGAR under the registrant records that have been Axsome Therapeutics Inc., going back to 2013; 281 of them are insider ownership forms (Forms 3, 4, 5 and 144).